Ownership history in Bayesian Capital Management, LP · 22 quarters on record
This page tracks every 13F SEC filing in which Bayesian Capital Management, LP reported a position in DEXCOM INC (DXCM). Data includes quarterly share count, position size as % of portfolio, estimated market value, and end-of-quarter stock price — sourced directly from SEC EDGAR 13F filings.
| Quarter | Action | Shares | Change | Chg % | % of Fund | Mkt Value | Price (EOQ) |
|---|---|---|---|---|---|---|---|
| 2025 Q4 | ADDED | 14,381 | +4,981 | +53.0% | 2.19% | $954K | $66.37 |
| 2025 Q3 | ADDED | 9,400 | +3,800 | +67.9% | 0.13% | $633K | $67.29 |
| 2024 Q2 | REDUCED | 5,600 | -48,436 | -89.6% | 0.07% | $635K | $113.38 |
| 2023 Q4 | ADDED | 54,036 | +20,000 | +58.8% | 0.71% | $6.7M | $124.09 |
| 2023 Q3 | ADDED | 34,036 | +24,200 | +246.0% | 0.36% | $3.2M | $93.30 |
| 2023 Q2 | ADDED | 9,836 | +1,433 | +17.1% | 0.14% | $1.3M | $128.51 |
| 2022 Q4 | ADDED | 8,403 | +1,403 | +20.0% | 0.14% | $952K | $113.24 |
| 2022 Q2 | ADDED | 7,000 | +5,390 | +334.8% | 0.10% | $522K | $74.53 |
| 2022 Q1 | REDUCED | 1,610 | -4,890 | -75.2% | 0.12% | $824K | $127.90 |
| 2020 Q4 | ADDED | 6,500 | +430 | +7.1% | 0.63% | $2.4M | $92.43 |
As of 2025 Q4 — sorted by position size